Landscapes / Companies
Nurix Therapeutics, Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
3
in active trials · 4 in all
Trials
6 active
10 since 2021
Drugs3
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 3 | Jan 2028Phase 2 trial completes | |||
| Next date | Jan 2028 · Phase 2 trial completes | ||||
| Also tested for | Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) and 10 more | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Ovarian Cancer, Epithelial, Gastric Cancer and 12 more | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) and 6 more | ||||
| Open drug page | |||||
About
- No active trial
- De-TIL-0255
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021